Modulation of inflammatory response

Modulation of inflammatory response refers to the regulation, upregulation, or downregulation, of various immune pathways involved in the onset, maintenance, and resolution of inflammation. This process involves the coordinated action of immune cell surface receptors (e.g., Toll-like receptors, interleukin receptors), intracellular signaling cascades (JAK-STAT, NF-κB, MAPK), and the downstream production of cytokines, chemokines, and other mediators that orchestrate the immune response to tissue injury or infection. Dysregulated modulation contributes to chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease and is a principal target of various modern immunomodulatory therapies[1][3][4].\n\nSummary of key points:\n- "Modulation of inflammatory response" is *not a molecule or target* but a process.\n- It encompasses multiple druggable protein targets (cytokines, receptors, kinases), but does not itself correspond to a unique protein, gene, or receptor[1][3][4].\n- For structured target databases, this entry should be flagged as not-a-target or unstructured.

Other names

Modulation of inflammationInflammatory response modulationInflammation regulation

Inhibition of pro-inflammatory cytokine signaling (e.g., TNF-α, IL-6); Inhibition of intracellular kinases (e.g., JAK inhibitors suppress cytokine signaling)[3]; Blockade of transcription factor activation (e.g., NF-κB inhibitors); Promotion of anti-inflammatory cytokine production; Modulation of metabolic pathways affecting immune cell function[7]